Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07832084) titled 'Comparing Different Medication Regimens to Maintaining Weight Loss Among Adults With Obesity Using GLP-1s' on Sept. 15.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Jing Luo
Condition:
Obesity & Overweight
Cardiometabolic Health Indicators
Intervention:
Drug: GLP-1 dose reduction
Drug: non-GLP weight loss medication
Drug: Maintenance of GLP-1 dose
Behavioral: Resistance exercise regimen
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: November 1, ...